Overview

A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2021-08-17
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to learn more about the safety and side effects of tirzepatide in Chinese participants with type 2 diabetes mellitus. The study will also measure how much tirzepatide gets into the bloodstream and how long it takes the body to remove it. The study will last about six or eight months for each participant.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Tirzepatide